trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Carcinoma D002277 18 associated lipids
Leishmaniasis D007896 19 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Schuhmann NK et al. Gene transfer into human cord blood-derived CD34(+) cells by adeno-associated viral vectors. 2010 Exp. Hematol. pmid:20447441
Hizume K et al. Nano-scale analyses of the chromatin decompaction induced by histone acetylation. 2010 Arch. Histol. Cytol. pmid:22572182
Legartova S et al. Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors. 2010 Neoplasma pmid:20568903
Kim J et al. PS-341 and histone deacetylase inhibitor synergistically induce apoptosis in head and neck squamous cell carcinoma cells. 2010 Mol. Cancer Ther. pmid:20571067
Obier N and Müller AM Chromatin flow cytometry identifies changes in epigenetic cell states. 2010 Cells Tissues Organs (Print) pmid:19776550
Fan J et al. Expression and function of CD9 in melanoma cells. 2010 Mol. Carcinog. pmid:19777564
Calonge TM et al. Transformation/transcription domain-associated protein (TRRAP)-mediated regulation of Wee1. 2010 Genetics pmid:20194963
Fakhry H et al. Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells. 2010 Hum. Pathol. pmid:20178884
Wood JP et al. A comparison of differentiation protocols for RGC-5 cells. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20181845
Das ZC et al. Lyophilized somatic cells direct embryonic development after whole cell intracytoplasmic injection into pig oocytes. 2010 Cryobiology pmid:20691649
Mercer TR et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. 2010 BMC Neurosci pmid:20137068
Heier CR et al. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. 2010 Hum. Mol. Genet. pmid:20693262
Chang J et al. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. 2010 World J. Gastroenterol. pmid:20066738
Huber K et al. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). 2010 J. Med. Chem. pmid:20030343
Kroening S et al. Characterization of connective tissue growth factor expression in primary cultures of human tubular epithelial cells: modulation by hypoxia. 2010 Am. J. Physiol. Renal Physiol. pmid:20032117
Kongruttanachok N et al. Replication independent DNA double-strand break retention may prevent genomic instability. 2010 Mol. Cancer pmid:20356374
Terracciano S et al. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. 2010 Bioorg. Med. Chem. pmid:20381359
Zhang LX et al. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. 2010 Am. J. Physiol. Heart Circ. Physiol. pmid:20382965
Dong G et al. Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells. 2010 Am. J. Physiol. Renal Physiol. pmid:19889954
Bhuiyan MM et al. Production of Sei whale (Balaenoptera borealis) cloned embryos by inter- and intra-species somatic cell nuclear transfer. 2010 J. Reprod. Dev. pmid:19893277
Ellis JK et al. Effect of the histone deacetylase inhibitor trichostatin a on the metabolome of cultured primary hepatocytes. 2010 J. Proteome Res. pmid:19894772
Zhao TC et al. gp-91 mediates histone deacetylase inhibition-induced cardioprotection. 2010 Biochim. Biophys. Acta pmid:20433879
Jeon HW and Lee YM Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression. 2010 Mol. Cancer Ther. pmid:20442303
Pollack BP et al. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. 2009 May-Jun Photochem. Photobiol. pmid:19076306
Chen Z et al. BCL11A represses HBG transcription in K562 cells. 2009 Mar-Apr Blood Cells Mol. Dis. pmid:19153051
Wang L et al. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. 2009 Mar-Apr Immunol. Cell Biol. pmid:19172156
Allritz C et al. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. 2009 Jul-Aug Neurochem. Int. pmid:19428803
Wallace DM and Cotter TG Histone deacetylase activity in conjunction with E2F-1 and p53 regulates Apaf-1 expression in 661W cells and the retina. 2009 J. Neurosci. Res. pmid:18951482
Li M et al. Upregulation of human with-no-lysine kinase-4 gene expression by GATA-1 acetylation. 2009 Int. J. Biochem. Cell Biol. pmid:18793746
Patel V et al. Identification and characterization of small molecule inhibitors of a class I histone deacetylase from Plasmodium falciparum. 2009 J. Med. Chem. pmid:19317450
García-Villegas R et al. Identification and functional characterization of the promoter of the mouse sodium-activated sodium channel Na(x) gene (Scn7a). 2009 J. Neurosci. Res. pmid:19326446
Seo J et al. Differential expression of stromal cell-derived factor 1 in human brain microvascular endothelial cells and pericytes involves histone modifications. 2009 Biochem. Biophys. Res. Commun. pmid:19289100
Cecconi D et al. Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 2009 Proteomics pmid:19294695
Ikeda S et al. Enhancement of histone acetylation by trichostatin A during in vitro fertilization of bovine oocytes affects cell number of the inner cell mass of the resulting blastocysts. 2009 Zygote pmid:19356267
Morita K et al. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. 2009 J. Neurosci. Res. pmid:19360904
Beebe LF et al. Cytochalasin B and trichostatin a treatment postactivation improves in vitro development of porcine somatic cell nuclear transfer embryos. 2009 Cloning Stem Cells pmid:19780698
Olsen CA and Ghadiri MR Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides. 2009 J. Med. Chem. pmid:19705846
Kee HJ and Kook H Krüppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. 2009 J. Mol. Cell. Cardiol. pmid:19729022
Ong DC et al. LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. 2009 Oncogene pmid:19734946
Alao JP et al. Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay. 2009 Mol. Cancer Ther. pmid:19723888
Bennett KL et al. AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma. 2009 PLoS ONE pmid:19742317
Meng CF et al. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells]. 2009 Zhonghua Wei Chang Wai Ke Za Zhi pmid:19742343
Dombrowsky H et al. Conserved responses to trichostatin A in rodent lungs exposed to endotoxin or stretch. 2009 Pulm Pharmacol Ther pmid:19744573
Chen FQ et al. Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. 2009 J. Neurochem. pmid:19141081
Zhao W et al. Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo. 2009 Cells Tissues Organs (Print) pmid:19147985
Sutcliffe EL et al. Dynamic histone variant exchange accompanies gene induction in T cells. 2009 Mol. Cell. Biol. pmid:19158270
Bagui TK et al. Inhibition of p27Kip1 gene transcription by mitogens. 2009 Cell Cycle pmid:19158484
Wang X et al. Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. 2009 Growth Factors pmid:19107653
Cao Y et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19966229
Trunzer M et al. Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS/MS validation. 2009 J. Med. Chem. pmid:19108654
Smil DV et al. Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19111466
Azzi A et al. Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors. 2009 Exp. Parasitol. pmid:19094990
Hambach L et al. Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. 2009 Blood pmid:19096014
Mavis CK et al. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. 2009 Prostate pmid:19444856
Samuni Y et al. The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation. 2009 Free Radic. Biol. Med. pmid:19447172
Gavin DP et al. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. 2009 J Psychiatry Neurosci pmid:19448855
Lee JH et al. Structural and functional studies of the yeast class II Hda1 histone deacetylase complex. 2009 J. Mol. Biol. pmid:19573535
Gan YH and Zhang S PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. 2009 Oral Oncol. pmid:19574087
Wang XX and Fu L [Recent advances in DNA demethylation in tumor therapy]. 2009 Zhonghua Bing Li Xue Za Zhi pmid:19575888
Sawarkar R et al. Histone deacetylases regulate multicellular development in the social amoeba Dictyostelium discoideum. 2009 J. Mol. Biol. pmid:19576222
Hsu PY et al. Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. 2009 Cancer Res. pmid:19549897
Noh H et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. 2009 Am. J. Physiol. Renal Physiol. pmid:19553350
Jonsen MD et al. The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain. 2009 Mol. Endocrinol. pmid:19556346
Link PA et al. Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells. 2009 Mol. Cancer Res. pmid:19531572
Chen IH et al. Cytotoxic triterpenoids from the stems of Microtropis japonica. 2009 J. Nat. Prod. pmid:19534471
Casero RA and Woster PM Recent advances in the development of polyamine analogues as antitumor agents. 2009 J. Med. Chem. pmid:19534534
Dubois F et al. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. 2009 Mol. Biochem. Parasitol. pmid:19538992
Ma XL et al. [Construction of anti-sense cDNA library of human breast cancer cells during apoptosis induced by trichostatin A and preliminary screening of essential genes]. 2009 Zhonghua Yi Xue Za Zhi pmid:19567099
Kim SN et al. Regulation of adipocyte differentiation by histone deacetylase inhibitors. 2009 Arch. Pharm. Res. pmid:19407971
Hirose N et al. ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells. 2009 Biochem. Biophys. Res. Commun. pmid:19422799
Park SJ et al. Trichostatin A sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by down-regulation of c-FLIPL via inhibition of EGFR pathway. 2009 Biochem. Pharmacol. pmid:19426671
Piotrowska H and Jagodzinski PP Glucocorticoid receptor alpha and beta variant expression is associated with ASF/SF2 splicing factor upregulation in HT-29 colon cancer and MCF-7 breast carcinoma cells. 2009 Arch. Med. Res. pmid:19427965
López-Soto A et al. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer. 2009 Oncogene pmid:19430493
Kim W et al. Histone acetyltransferase GCN5 interferes with the miRNA pathway in Arabidopsis. 2009 Cell Res. pmid:19436261
Yoshida M Chemical genomics: a key to the epigenome - an interview with Minoru Yoshida. Interview by Saadi Khochbin. 2009 Int. J. Dev. Biol. pmid:19412886
Han DW et al. Epigenetic hierarchy governing Nestin expression. 2009 Stem Cells pmid:19415779
Derks S et al. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. 2009 Carcinogenesis pmid:19329758
Liu X et al. The improvement of adenovirus vector production by increased expression of coxsackie adenovirus receptor. 2009 Biotechnol. Lett. pmid:19330491
Hollosi P et al. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. 2009 Int. J. Cancer pmid:19330836
Kusakabe M et al. Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonists. 2009 Biochem. Biophys. Res. Commun. pmid:19878646
Ma X et al. Identification of LIV1, a putative zinc transporter gene responsible for HDACi-induced apoptosis, using a functional gene screen approach. 2009 Mol. Cancer Ther. pmid:19887557
Puca R et al. HIPK2 modulates p53 activity towards pro-apoptotic transcription. 2009 Mol. Cancer pmid:19828042
Röhrs S et al. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. 2009 Mol. Cancer pmid:19835597
Wang Y et al. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. 2009 Neurosci. Lett. pmid:19835929
Kawamura T et al. Inhibitory effects of short-chain fatty acids on matrix metalloproteinase secretion from human colonic subepithelial myofibroblasts. 2009 Dig. Dis. Sci. pmid:18629644
Kakihana M et al. Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition. 2009 J Thorac Oncol pmid:20009910
O'Leary DA et al. Identification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screening. 2009 PLoS ONE pmid:20020055
Halaban R et al. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications. 2009 PLoS ONE pmid:19234609
Maalouf WE et al. Trichostatin A treatment of cloned mouse embryos improves constitutive heterochromatin remodeling as well as developmental potential to term. 2009 BMC Dev. Biol. pmid:19210795
Sakurai T et al. Induction of endogenous interferon tau gene transcription by CDX2 and high acetylation in bovine nontrophoblast cells. 2009 Biol. Reprod. pmid:19211809
Chakravorty M et al. IL1B promoter polymorphism regulates the expression of gastric acid stimulating hormone gastrin. 2009 Int. J. Biochem. Cell Biol. pmid:19166966
Zhang D et al. [Synergistic cytotoxicity effect of histone deacetylase inhibitor combined with paclitaxel on lung cancer cell lines and its mechanism]. 2009 Ai Zheng pmid:19958621
Lu MC et al. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. 2009 Arch. Toxicol. pmid:18709356
Sharma A et al. Trichostatin a inhibits corneal haze in vitro and in vivo. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19168895
Li X et al. Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos. 2009 Blood pmid:19864643
Zubia A et al. Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. 2009 Oncogene pmid:19169274
Meng Q et al. Live birth of somatic cell-cloned rabbits following trichostatin A treatment and cotransfer of parthenogenetic embryos. 2009 Cloning Stem Cells pmid:19196041
Gray SG et al. Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. 2009 Eur. J. Cancer pmid:19818596
Hara D et al. Persistent BDNF exon I-IX mRNA expression following the withdrawal of neuronal activity in neurons. 2009 Biochem. Biophys. Res. Commun. pmid:19818730
Li C et al. Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression. 2009 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:19821084